The aberrant expression of human endogenous retrovirus (HERV) elements of the HERV-W family has been associated with different diseases, including multiple sclerosis (MS). In particular, the expression of the envelope protein (Env) from the multiple sclerosis-associated retrovirus (MSRV), a member of HERV-W family and known for its potent proinflammatory activity, is repeatedly detected in the brain lesions and blood of MS patients. Furthermore, human herpesvirus 6 (HHV-6) infection has long been suspected to play a role in the pathogenesis of MS and neuroinflammation. We show here that both HHV-6A and stimulation of its receptor, transmembrane glycoprotein CD46, induce the expression of MSRV-Env. The engagement of extracellular domains SCR3 and SCR4 of CD46-Cyt1 isoform was required for MSRV-env transactivation, limiting thus the MSRV-Env induction to the CD46 ligands binding these domains, including C3b component of complement, specific monoclonal antibodies, and both infectious and UV-inactivated HHV-6A, but neither HHV-6B nor measles virus vaccine strain. Induction of MSRV-Env required CD46 Cyt-1 singling and was abolished by the inhibitors of protein kinase C. Finally, both membrane-expressed and secreted MSRV-Env trigger TLR4 signaling, displaying thus a proinflammatory potential, characteristic for this viral protein. These data expand the specter of HHV-6A effects in the modulation of the immune response and support the hypothesis that cross-talks between exogenous and endogenous viruses may contribute to inflammatory diseases and participate in neuroinflammation. Furthermore, they reveal a new function of CD46, known as an inhibitor of complement activation and receptor for several pathogens, in transactivation of HERV genes, which may play an important role in the pathogenesis of inflammatory diseases.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6291489PMC
http://dx.doi.org/10.3389/fimmu.2018.02803DOI Listing

Publication Analysis

Top Keywords

multiple sclerosis-associated
8
sclerosis-associated retrovirus
8
envelope protein
8
herv-w family
8
play role
8
role pathogenesis
8
inflammatory diseases
8
cd46
5
msrv-env
5
induction proinflammatory
4

Similar Publications

In multiple sclerosis (MS) the circulating metabolome is dysregulated, with indole lactate (ILA) being one of the most significantly reduced metabolites. We demonstrate that oral supplementation of ILA impacts key MS disease processes in two preclinical models. ILA reduces neuroinflammation by dampening immune cell activation/ infiltration; and promotes remyelination and oligodendrocyte differentiation through the aryl hydrocarbon receptor (AhR).

View Article and Find Full Text PDF

Prognosis of patients with multiple sclerosis associated with uveitis.

Mult Scler Relat Disord

October 2023

Department of Neurology Pitié-Salpêtrière Hospital, Sorbonne University, APHP-6, 47-83 Boulevard de l'hôpital, Paris, France. Electronic address:

Background: Uveitis may be associated with multiple sclerosis (MS) in 1% of cases. Prognosis of this association remains unknown.

Methods: We conducted a retrospective analysis in a cohort of 41 patients with MS (34 relapsing-remitting MS, and 7 secondary progressive MS) matched with 123 controls (MS without uveitis) followed in Department of Neurology, Pitié Salpêtrière Hospital, Paris.

View Article and Find Full Text PDF

Multiple sclerosis-associated uveitis in Persian population, a multicenter study.

Mult Scler Relat Disord

December 2024

Department of Ophthalmology, College of Medicine, University of Florida, Gainesville, FL 32611, USA. Electronic address:

Purpose: To report the characteristics of multiple sclerosis-associated uveitis (MSU) among the Persian population.

Patients And Methods: Retrospective, nonrandomized, multicenter study. Epidemiological characteristics, ocular and neurologic findings, angiographic features, and visual outcomes in MSU were studied.

View Article and Find Full Text PDF

Uveitis characteristics and multiple sclerosis phenotype of patients with multiple sclerosis-associated uveitis: A systematic review and meta-analysis.

PLoS One

October 2024

Ophthalmology Interest Group-Universidad del Rosario (OIG UR), Neuroscience (NEUROS) Research Group, Neurovitae Research Center, Institute of Translational Medicine (IMT), Escuela de Medicina y Ciencias de la Salud, Universidad del Rosario, Bogotá, Colombia.

Article Synopsis
  • - Purpose: The study aimed to summarize and analyze the characteristics of uveitis and the phenotype of multiple sclerosis (MS) in patients with multiple sclerosis-associated uveitis (MSAU) through a systematic review and meta-analysis conducted on data up to January 2023.
  • - Methods: A thorough literature search was conducted across multiple databases, focusing on relevant studies involving patients with MSAU. The analysis included various study designs, assessing quality and risk of bias, and examining uveitis characteristics and MS phenotype using statistical software.
  • - Results: The meta-analysis covered 36 studies with 1,257 patients revealing a mean patient age of 38.2 years, with most cases being female (67%). Notably
View Article and Find Full Text PDF

Autologous hematopoietic stem cell transplant for systemic sclerosis associated interstitial lung disease.

Curr Opin Rheumatol

November 2024

Yale School of Medicine, Department of Internal Medicine, Section of Pulmonary, Critical Care and Sleep Medicine, New Haven, Connecticut, USA.

Article Synopsis
  • * Most studies view lung issues as secondary concerns, often excluding patients with serious lung problems, yet emerging evidence suggests HSCT may stabilize or even improve lung function in some cases.
  • * HSCT shows better long-term outcomes than traditional therapies for dcSSc, highlighting the need for future research to improve patient selection, treatment protocols, and specifically address interstitial lung disease, the primary cause of death in systemic sclerosis.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!